Michael S. Donoviel
Lexicon Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Lysosomal Storage Disorders Research, Endoplasmic Reticulum Stress and Disease, Lipid Membrane Structure and Behavior, Fungal and yeast genetics research
Most-Cited Works
- → A Family of Cyclin-Like Proteins That Interact with the Pho85 Cyclin-Dependent Kinase(1997)199 cited
- → Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions(2008)158 cited
- → Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)(2010)110 cited
- → Spinster 2, a sphingosine‐1‐phosphate transporter, plays a critical role in inflammatory and autoimmune diseases(2015)78 cited
- → Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders(2009)74 cited
- → High‐throughput Screening of Mouse Knockout Lines Identifies True Lean and Obese Phenotypes(2008)61 cited
- → Adjacent upstream activation sequence elements synergistically regulate transcription of ADH2 in Saccharomyces cerevisiae.(1989)57 cited
- → Cloning and characterization of Sel-1l, a murine homolog of the C. elegans sel-1 gene(1998)52 cited
- → Molecular cloning of the sphingolipid activator protein — 1 (SAP - 1), the sulfatide sulfatase activator(1986)36 cited
- → A Heterodimeric Transcriptional Repressor Becomes Crystal Clear(1995)22 cited